During the past decade, Katayama Medical Clinic conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 5 clinical trials were completed, i.e. on
average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Primary Prevention of Major Adverse Cardiac Events (MACE) With Standard and Intensive Statin Treatment in Patients With Diabetes: Survival and Cardiovascular Event Assessments
A Study To Evaluate The Safety And Efficacy Of Tofacitinib Modified Release Tablets Compared To Tofacitinib Immediate Release Tablets In Adult Patients With Rheumatoid Arthritis
A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira®) In Combination With Methotrexate In Subjects With Active Rheumatoid Arthritis (REFLECTIONS B538-02).
A Study of LY3372689 to Assess the Safety, Tolerability, and Efficacy in Participants With Alzheimer's Disease
2021-09-16
2024-06-13
Active, not recruiting
330
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Katayama Medical Clinic" #1 sponsor was "AstraZeneca" with 2 trials, followed by "Eli Lilly and Company" with 2 trials
sponsored, "Pfizer" with 2 trials sponsored, "Listen Trial Group" with 1 trials sponsored and "Positive Trial Group"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Katayama Medical Clinic"
#1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Katayama Medical Clinic
According to Clinical.Site data, the most researched conditions in "Katayama Medical Clinic" are
"Alzheimer Disease" (2 trials), "Rheumatoid Arthritis" (2 trials), "Alzheimer's Disease" (1 trials), "Alzheimer´s Disease" (1 trials) and "Hypercholesterolemia" (1 trials). Many other conditions were trialed in "Katayama Medical Clinic" in a lesser frequency.
Clinical Trials Intervention Types at Katayama Medical Clinic
Most popular intervention types in "Katayama Medical Clinic" are "Drug" (7 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Lanabecestat" (2 trials), "Rosuvastatin" (2 trials), "Adalimumab" (1 trials) and "Atorvastatin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Katayama Medical Clinic
The vast majority of trials in "Katayama Medical Clinic" are
8 trials for "All" genders.
Clinical Trials Status at Katayama Medical Clinic
Currently, there are NaN active trials in "Katayama Medical Clinic".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Katayama Medical Clinic,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Katayama Medical Clinic, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".